Pattern electroretinogram changes after intravitreal bevacizumab injection for diabetic macular edema

Documenta Ophthalmologica

Volumn 120, Issue 3, 2010, Pages 243-250

  Ozkiriş, Abdullah ^a,b  

^a ACIBADEM UNIVERSITY   (Turkey)

^b Melikgazi Mah Mustafa Simsek   (Turkey)

Author keywords

Diabetic macular edema; Intravitreal bevacizumab; Pattern electroretinogram

Indexed keywords

BEVACIZUMAB;

ADULT; ANTERIOR EYE CHAMBER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DRUG EFFICACY; ELECTRORETINOGRAM; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; OUTCOME ASSESSMENT; PATTERN ELECTRORETINOGRAM; PRIORITY JOURNAL; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 77953231242     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10633-010-9219-0     Document Type: Article

References (29)

1. C Pelzek JI Lim 2002 Diabetic macular edema: review and update Ophthalmol Clin North Am. 15 555 563 10.1016/S0896-1549(02)00043-3 12515087 (Pubitemid 36076610)
2. RJ Antcliff J Marshall 1999 The pathogenesis of edema in diabetic maculopathy Semin Ophthalmol. 14 223 232 10.3109/08820539909069541 1:STN:280:DC%2BD3c3isVSitw%3D%3D 10758223
3. TA Ciulla AG Amador B Zinman 2003 Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies Diabetes Care 26 2653 2664 10.2337/diacare.26.9.2653 12941734 (Pubitemid 37055447)
4. Early Treatment Diabetic Retinopathy Study Research Group 1987 Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early treatment diabetic retinopathy study report number 2 Ophthalmology 94 761 774
5. A Ozkiris C Evereklioglu A Oner K Erkilic 2004 Pattern electroretinogram for monitoring the efficacy of intravitreal triamcinolone injection in diabetic macular edema Doc Ophthalmol. 109 139 145 10.1007/s10633-004-2956-1 15881259 (Pubitemid 40468408)
6. A Ozkiris C Evereklioglu K Erkilic N Tamcelik E Mirza 2004 Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema Eur J Ophthalmol 14 543 549 1:STN:280:DC%2BD2M%2Fht1Gluw%3D%3D 15638105
7. JB Jonas BA Kamppeter B Harder U Vossmerbaeumer G Sauder UH Spandau 2006 Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study J Ocul Pharmacol Ther. 22 200 207 10.1089/jop.2006.22.200 1:CAS:528:DC%2BD28XmtlGrtb0%3D 16808682 (Pubitemid 44051133)
8. A Martidis JS Duker PB Greenberg AH Rogers CA Puliafito E Reichel C Baumal 2002 Intravitreal triamcinolone for refractory diabetic macular edema Ophthalmology. 109 920 927 10.1016/S0161-6420(02)00975-2 11986098 (Pubitemid 34465226)
9. C Haritoglou D Kook A Neubauer A Wolf S Priglinger R Strauss A Gandorfer M Ulbig A Kampik 2006 Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema Retina. 26 999 1005 10.1097/01.iae.0000247165. 38655.bf 17151486 (Pubitemid 44973218)
10. JF Arevalo J Fromow-Guerra H Quiroz-Mercado JG Sanchez L Wu M Maia MH Berrocal A Solis-Vivanco ME Farah Pan-American Collaborative Retina Study Group 2007 Primary intravitreal bevacizumab (Avastin) for diabetic macular edema Ophthalmology. 114 743 750 10.1016/j.ophtha.2006.12.028 17398322 (Pubitemid 46483714)
11. T Otani S Kishi 2002 A controlled study of vitrectomy for diabetic macular edema Am J Ophthalmol 134 214 229 10.1016/S0002-9394(02)01548-9 12140028 (Pubitemid 34831825)
12. T Yamamoto N Akabane S Takeuchi 2001 Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane Am J Ophthalmol 132 369 377 10.1016/S0002-9394(01)01050-9 1:STN:280: DC%2BD3MvoslOlsA%3D%3D 11530050 (Pubitemid 32768606)
13. GE Holder 2001 Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis Prog Retin Eye Res. 20 531 561 10.1016/S1350-9462(00)00030-6 1:STN:280:DC%2BD3MzitVKntQ%3D%3D 11390258 (Pubitemid 32523897)
14. Maffei L, Fiorentini A (1986) Generator sources of the pattern ERG in man and animals. In: Cracco RQ, Bodis-Wollner I (eds) Frontiers in clinical neuroscience. vol. 3. Liss, New York, pp 101-116
15. J Larsson S Andreasson 2001 Photopic 30 Hz flicker ERG as a predictor for rubeosis in central retinal vein occlusion Br J Ophthalmol 85 683 685 10.1136/bjo.85.6.683 1:STN:280:DC%2BD3M3nslKkug%3D%3D 11371488 (Pubitemid 32554246)
16. J Larsson B Bauer U Cavallin-Sjoberg S Andreasson 1998 Fluorescein angiography versus ERG for predicting the prognosis in central retinal vein occlusion Acta Ophthalmol Scand 76 456 460 10.1034/j.1600-0420.1998.760412.x 1:STN:280:DyaK1czotVWqsg%3D%3D 9716333
17. GE Holder MG Brigell M Hawlina T Meigen BachM Vaegan International Society for Clinical Electrophysiology of Vision 2007 ISCEV standard for clinical pattern electroretinography-2007 update Doc Ophthalmol. 114 111 116 10.1007/s10633-007-9053-1 17435967 (Pubitemid 46681692)
18. U Ozerdem WR Freeman 2001 Exudative retinal detachment following grid laser photocoagulation in a patient with hemiretinal vein occlusion Eur J Ophthalmol 11 89 92 1:STN:280:DC%2BD3MvjsVKhsw%3D%3D 11284495
19. M Lovestam-Adrian E Agardh 2000 Photocoagulation of diabetic macular oedema-complications and visual outcome Acta Ophthalmol Scand 78 667 671 10.1034/j.1600-0420.2000.078006667.x 1:STN:280:DC%2BD3M7jtFalug%3D%3D 11167229
20. A Ozkiris K Erkilic 2005 Complications of intravitreal injection of triamcinolone acetonide Can J Ophthalmol 40 63 68 15825532
21. JB Jonas I Kreissig RF Degenring 2004 Retinal complications of intravitreal injections of triamcinolone acetonide Graefes Arch Clin Exp Ophthalmol. 242 184 185 10.1007/s00417-003-0841-3 14676960 (Pubitemid 38324974)
22. ET Cunningham Jr AP Adamis M Altaweel LP Aiello NM Bressler DJ D'Amico M Goldbaum DR Guyer B Katz M Patel SD Schwartz Macugen Diabetic Retinopathy Study Group 2005 A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema Ophthalmology. 112 1747 1757 10.1016/j.ophtha.2005.06.007 16154196 (Pubitemid 41400011)
23. RA Costa R Jorge D Calucci LA Melo Jr JA Cardillo IU Scott 2007 Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study Retina. 27 141 149 10.1097/IAE.0b013e31802eff83 17290194
24. L Feiner EE Barr YB Shui NM Holekamp MA Brantley Jr 2006 Safety of intravitreal injection of bevacizumab in rabbit eyes Retina. 26 882 888 10.1097/01.iae.0000230717.85319.f5 17031287 (Pubitemid 44547440)
25. F Ziemssen S Grisanti KU Bartz-Schmidt 2006 The international intravitreal bevacizumab safety survey Br J Ophthalmol 90 1440 1441 10.1136/bjo.2006.092262 1:STN:280:DC%2BD28nit1SqsQ%3D%3D 17057183 (Pubitemid 43974012)
26. SA Pai R Shetty GV Vijayan PB NK Yadav BK Shetty RB Babu KM Narayana 2007 Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion Am J Ophthalmol 143 601 606 10.1016/j.ajo.2006.12.037 1:CAS:528:DC%2BD2sXjsVWitbw%3D 17306753 (Pubitemid 46452523)
27. AJ Augustin S Puls I Offermann 2007 Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone Retina. 27 133 140 10.1097/IAE.0b013e3180323de7 17290193
28. JO Mason 3rd MA Albert Jr R Vail 2006 Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema Retina. 26 356 357 10.1097/00006982-200603000-00018 16508440 (Pubitemid 44318197)
29. B Falsini V Porciatti G Scalia S Caputo A Minnella MA Di Leo G Ghirlanda 1989 Steady-state pattern electroretinogram in insulin-dependent diabetics with no or minimal retinopathy Doc Ophthalmol. 73 193 200 10.1007/BF00155037 1:STN:280:DyaK3c3pvVOmtQ%3D%3D 2638628 (Pubitemid 20238190)